MAPT and Alzheimer disease: This indicates that among A+ cognitively unimpaired individuals, who are presumably already on the AD pathological continuum, the coexistence of tau pathological changes in the MTL and/or the neocortex represents a ssubstantial additional relative risk for short-term cognitive decline.